Rapamycin contains the active ingredient sirolimus, a macrolide immunosuppressant. It is classified as an autoimmune support agent because of its ability to modulate immune system activity. The medication is supplied as a pill in a 1 mg strength. In Hong Kong, rapamycin is a prescription-only product regulated by the Department of Health (aligned with the WHO-based schedule for controlled medicines). Commercially, rapamycin is marketed under various brand names; the generic name is sirolimus.
Rapamycin exerts its effects by inhibiting the mammalian target of rapamycin (mTOR) pathway. mTOR is a key intracellular protein kinase that regulates cell growth, proliferation, and survival. By binding to the intracellular protein FKBP-12, rapamycin forms a complex that blocks mTOR-C1 activity. This results in:
The onset of immunosuppressive activity typically occurs within hours of the first dose, with peak blood concentrations reached in 1-2 hours after oral ingestion. The drug’s half-life ranges from 55 to 80 hours, allowing once-daily dosing once a stable therapeutic level is achieved.
Rapamycin (sirolimus) is FDA- and EMA-approved for the following indications, which also apply under Hong Kong regulatory guidance:
While rapamycin is not formally approved for mainstream autoimmune diseases, its mTOR-inhibiting properties have prompted investigational interest in conditions such as systemic lupus erythematosus and rheumatoid arthritis. Use for these purposes remains off-label and should occur only under specialist supervision.
Disclaimer: Off-label use of rapamycin requires careful medical supervision, individualized risk assessment, and regular monitoring of blood levels.
Note: Patients should disclose all prescription drugs, over-the-counter medicines, supplements, and herbal products to their healthcare provider before starting rapamycin.
This article provides educational information about rapamycin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, but you should carry the medication in its original labeled container, include a copy of the prescription, and keep it in your carry-on luggage to avoid temperature extremes. Some countries may require a doctor’s note, so check entry requirements in advance.
Rapamycin is not a substance screened for in standard employment drug tests. However, if you are subject to specialized testing (e.g., for clinical trials), inform the testing laboratory of your medication.
Manufacturers typically imprint the tablet with a code that includes “1 mg” and a brand identifier; the exact appearance can vary by supplier. Verify the imprint against the pharmacy label to ensure authenticity.
St John’s wort, an herbal CYP3A4 inducer, may lower rapamycin levels, reducing effectiveness. Conversely, grapefruit juice can inhibit CYP3A4 and raise drug concentrations. Discuss any herbal products with your provider.
When stored correctly at room temperature and kept tightly sealed, the tablet retains its potency until the printed expiration date, usually 24-36 months from manufacture.
Coverage varies based on clinical indication and eligibility criteria. Patients undergoing organ transplantation are more likely to receive reimbursement; contact your hospital’s pharmacy for specifics.
Both are immunosuppressants but target different pathways: rapamycin inhibits mTOR, while tacrolimus blocks calcineurin. Their side-effect profiles and drug-interaction potentials also differ.
Immunosuppressive therapy may attenuate vaccine response. Current guidance advises timing vaccination before initiating rapamycin or, if already on therapy, discussing optimal scheduling with a specialist.
Some formulations employ a thin polymer coating to improve swallowability and protect the active ingredient from moisture. The coating does not affect drug absorption significantly.
